Research Labs
Our innovative research focuses on four areas:
- Basic research
- Next-generation therapeutics
- HIV prevention-vaccine development
- Passive administration of neutralizing antibodies and microbicides
-
The Goff lab studies the life cycle of retroviruses, and performs screens to identify and characterize restriction factors that inhibit virus replication and the host factors that they require.
-
The Ho Lab is committed to finding scientific solutions to end the HIV/AIDS pandemic and using the techniques acquired in their decades of HIV research to the novel coronavirus SARS-CoV-2.
-
The Huang Lab devotes efforts to develop HIV vaccine and antibody-based strategies and long-acting antiretroviral drugs as pre-exposure prophylaxis to halt or slow the spread of AIDS.
-
The Iketani Lab is focused on developing scalable strategies that contribute to answering basic and translational virology questions, particularly for pandemic preparedness and virological discovery.
-
The Liu lab studies viral evolution and immune responses to develop novel diagnostics, prophylactics, and/or therapeutics that combat emerging and re-emerging viruses.
-
Dr. Meyers’ lab addresses health inequity by accelerating translation of scientific discoveries into public health interventions accessible to marginalized populations, with a particular focus on HIV.
-
The focus of the Sabo Lab is to expand our understanding of cellular host factors and their interaction with specific infecting viral pathogens: HIV-1 and the human respiratory syncytial virus (HRSV).
-
The goal of the Sheng Lab is to use interdisciplinary approaches to understand the mechanisms of antibody maturation and disease etiology, and to find therapeutic targets for disease prevention.
-
The Tsuji Lab's research projects are applied and translational, seeking to further understanding of host immune system for development of effective vaccines against infectious diseases and cancer.
-
The focus of the Wu Lab is to elucidate the mechanisms by which the HIV-1 envelope glycoprotein elicits neutralizing antibody responses in humans and rhesus macaques for HIV-1 vaccine development.
-
The Yamashita Lab studies the biology of human immunodeficiency virus to elucidate the fundamental principles of viral replication and to develop novel drug design strategies.